Tag: Tucker Carlson

Browse our exclusive articles!

Elon Musk Announces Plans to Launch Rival to Microsoft-Backed ChatGPT AI Platform

. Billionaire Elon Musk has announced plans to launch a new Artificial Intelligence (AI) platform called "TruthGPT" in response to offerings from Microsoft and Google. He has accused OpenAI of "training the AI to lie" and of being a "for-profit" company. Musk plans to create a "maximum truth-seeking AI" for Artificial Intelligence safety. His platform is expected to compete against OpenAI, which he founded in 2015. Microsoft recently invested billions of dollars into this initiative. Join the race for the best AI in Silicon Valley and find out more about Musk's mission.

Elon Musk Developing AI Platform to Compete with ChatGPT

Elon Musk has caused a stir in AI by proposing a new platform to rival OpenAI, which is backed by Microsoft. He speaks out against them, claiming they are a "closed-source, for-profit organization" and accuses Larry Page, co-founder of Google, of not taking AI safety seriously. Musk has since created a "maximum truth-seeking AI" called "TruthGPT", promising improved AI safety. He has taken steps to launch a competing platform, poaching AI researchers from Google and setting up a firm in Nevada. He believes AI will be more dangerous than mismanaged design and warns of "civilizational destruction". He has called for a six-month pause on developing more powerful AI than OpenAI's GPT-4. His own venture in Twitter has ended in selling the company for "less than half" the purchase price. OpenAI, Page and Musk have not responded to Reuters so far.

Elon Musk Developing AI Platform to Compete with ChatGPT

Elon Musk has caused a stir in AI by proposing a new platform to rival OpenAI, which is backed by Microsoft. He speaks out against them, claiming they are a "closed-source, for-profit organization" and accuses Larry Page, co-founder of Google, of not taking AI safety seriously. Musk has since created a "maximum truth-seeking AI" called "TruthGPT", promising improved AI safety. He has taken steps to launch a competing platform, poaching AI researchers from Google and setting up a firm in Nevada. He believes AI will be more dangerous than mismanaged design and warns of "civilizational destruction". He has called for a six-month pause on developing more powerful AI than OpenAI's GPT-4. His own venture in Twitter has ended in selling the company for "less than half" the purchase price. OpenAI, Page and Musk have not responded to Reuters so far.

Fox News and Dominion Seek Settlement in Defamation Case as Trial Date Delays

Dominion Voting Systems has taken Fox News to court, with a defamation case that seeks $1.6 billion in damages. The case relates to false claims made by Rudy Giuliani and Sidney Powell in relation to the election, which were broadcast by Fox. Proceedings got underway in the Delaware Superior Court, with Fox attempting to settle the case before trial. Judge Eric M. Davis ruled largely in Dominion’s favor, and in preparation for a potentially lengthy trial, Abby Grossburg filed two lawsuits against Fox. Smartmatic, a rival election technology company, had filed a separate $2.7 billion suit against Fox in the New York courts.

Sam Altman Responds: OpenAI CEO Comments on Elon Musk-Backed Letter for AI Halt

OpenAI CEO Sam Altman recently responded to a letter signed by tech leaders, including Twitter CEO Elon Musk and Apple co-founder Steve Wozniak, which proposed to pause powerful AI experiments. During a virtual event at MIT, Altman shared his opinion and emphasized on the safety protocols suggested and the six-month research OpenAI conducted before the release of ChatGPT 4. Musk, Wozniak and over 1,000 other tech leaders believe AI experiments should resume responsibly and protocols should be set in place to ensure safe development.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img